Helius Medical Technologies, Inc.
HSDT
$4.18
-$0.24-5.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 390.00K | 476.00K | 458.00K | 550.00K | 623.00K |
| Total Other Revenue | 44.00K | 44.00K | 44.00K | 44.00K | 45.00K |
| Total Revenue | 434.00K | 520.00K | 502.00K | 594.00K | 668.00K |
| Cost of Revenue | 580.00K | 582.00K | 518.00K | 518.00K | 584.00K |
| Gross Profit | -146.00K | -62.00K | -16.00K | 76.00K | 84.00K |
| SG&A Expenses | 10.48M | 10.12M | 9.57M | 8.92M | 9.03M |
| Depreciation & Amortization | 17.00K | 24.00K | 29.00K | 54.00K | 85.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.89M | 14.38M | 13.50M | 12.52M | 12.54M |
| Operating Income | -14.46M | -13.86M | -13.00M | -11.93M | -11.88M |
| Income Before Tax | -13.06M | -11.74M | -8.86M | -8.84M | -8.87M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.06 | -11.74 | -8.86 | -8.84 | -8.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.06M | -11.74M | -8.86M | -8.84M | -8.87M |
| EBIT | -14.46M | -13.86M | -13.00M | -11.93M | -11.88M |
| EBITDA | -14.41M | -13.80M | -12.93M | -11.83M | -11.75M |
| EPS Basic | -47.72 | -86.28 | -92.68 | -160.17 | -194.37 |
| Normalized Basic EPS | -29.73 | -53.82 | -57.93 | -97.88 | -119.25 |
| EPS Diluted | -47.82 | -86.37 | -92.78 | -160.28 | -194.48 |
| Normalized Diluted EPS | -29.73 | -53.82 | -57.93 | -97.88 | -119.25 |
| Average Basic Shares Outstanding | 1.17M | 721.70K | 519.00K | 314.10K | 183.80K |
| Average Diluted Shares Outstanding | 1.17M | 721.70K | 519.00K | 314.10K | 183.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |